Profile of:

Asim Khan

Dr. Muhammad Asim Khan obtained his medical degree in 1965, and after 2 years of Army Service, he obtained his postgraduate training in the UK and the US. He completed his rheumatology fellowship in Cleveland, OH in 1973 and joined the faculty of Case Western Reserve University in that city. He served there till 2012 as a tenured full Professor of Medicine when he was awarded the title of Professor Emeritus of Medicine. Three years later he was inducted into the Medical Hall of Honor at MetroHealth Medical Center, the hospital he has served since 1971. He has been elected as a Master of both the American College of Physicians (ACP) and the American College of Rheumatology (ACR), and a Fellow of the Royal College of Physicians of UK (FRCP). He is a recipient of the ACR’s Distinguished Rheumatologist Award and the Ohio Association of Rheumatology's Lifetime Achievement Award. He had served as a member of the National Advisory Board for the National Institute of Arthritis and Musculoskeletal and Skin Disorders (NIAMS). His research interests center around the clinical, immunogenetic and therapeutic aspects of rheumatic diseases, with special focus on ankylosing spondylitis (AS) and related forms of spondyloarthritis (SpA). He has published 3 books and edited 4 others, and has authored >50 book chapters and >245 journal articles, in addition to >185 scientific abstracts and letters to editor. He is the Section Editor for SpA for the journal Curr Rheumatol Rep since 2006, after having served in the same role from 1993 to 2001 for Curr Opin Rheumatol. He is a peer reviewer for UpToDate, and has served as an editorial board member or a reviewer for several journals. He is one of the founding members of ASAS, SPARTAN, and GRAPPA, and a recipient of SPARTAN's Lifetime Achievement Award. He has served on various advisory committees in these organizations, as well as the ACR, ACP, and the Spondylitis Association of America (SAA). He has been suffering from severe AS since age 12, and was bestowed an award from the SAA for a "lifetime of dedication and devotion to people with spondylitis" and also their Greg Field Award that is given to "individuals with AS who have persevered and gone on to be of service to others”.

Full name: Asim Khan

Current country: United States

Membership level: Full

Type of membership: Honorary

Number of publications: 12

van der Linden S, Khan MA, Li Z, Baumberger H, Zandwijk HV, Khan K, Villiger P, Brown MA. Factors predicting axial spondlyoarthritis among first-degree relatives of probands with ankylosing spondylitis. A family study spanning 35 years. Ann Rheum Dis. 2022; 81(6):831-7. doi: 10.1136/annrheumdis-2021-222083 (2022)

Li Z, van der Linden S, Khan MA, Baumberger H, Zandwijk HV, Khan MK, Villiger P, Brown MA. Heterogeneity of Axial Spondyloarthritis – Genetics, Sex and Structural Damage Matter. RMD Open. 2022;8:e002302. doi:10.1136/ rmdopen-2022-002302 (2022)

van der Linden S, Khan MA, Baumberger H, Li Z, Zandwijk HV, Khan MK, Villiger P, Brown MA. Recurrence of Axial Spondyloarthritis among First-Degree Relatives in a Prospective 35-year-follow-up Family Study. RMD Open. 2022;8:e002208. doi:10.1136/ rmdopen-2022-002208 (2022)

Couto AR, Parreira B, Power DM, Pinheiro L, Dias JM, Novofastovski I, Eshed I, Sarzi-Puttini P, Pappone N, Atzeni F, Verlaan JJ, Kuperus J, Bieber A, Ambrosino P, Kiefer D, Khan MA, Mader R, Baraliakos X and Armas JB. Evidence for a genetic contribution to the ossification of spinal ligaments in Ossification of Posterior Longitudinal Ligament and Diffuse idiopathic skeletal hyperostosis: A narrative review. Frontier Genetics. 13:987867. doi: 10.3389/fgene.2022.987867 (2022)

Robinson PC, van der Linden S, Khan MA, Taylor WJ. Axial Spondyloarthritis: Concept, construct, classification and implications for therapy. Nat Rev Rheumatol. 2021 Feb(2);17(2):109-118 (2021)

Mader R, Pappone N, Baraliakos X,……… Khan MA. Diffuse Idiopathic Skeletal Hyperostosis (DISH) and a Possible Inflammatory Component. Curr Rheumatol Rep. 23, 6 (2021). doi: 10.1007/s11926-020-00972-x (2021)

Akkoc N, Khan MA. JAK inhibitors for axial spondyloarthritis: What does the future hold? Curr Rheumatol Rep. 23, 34 (2021). doi: 10.1007/s11926-021-01001-1 (2021)

Klitz U, Boonen A, van der Heijde D, ,…. Khan MA, …. Braun J. Developmentof important contextual item set relevant to global functioning and health in patients with axial spondyloarthritis – the Environmental Factor Item Set accompanying the ASAS Health Index. Rheumatology. doi: 10.1093/rheumatology/keab653 (2021)

Bittar M, Yong WC, Magrey M, Khan MA. Worldwide Differences in Clinical Phenotype of Axial Spondyloarthritis. Curr Rheumatol Rep. 23, 76 (2021). doi: 10.1007/s11926-021-01043-5 (2021)

Chetrit M, Kapadia S. Khan MA. State of the art management of aortic valve disease in ankylosing spondylitis. Curr Rheumatol Rep. 2020 May 14;22(6):23. (2020)

Akkoc N, Khan MA. Is axial spondyloarthritis more common than rheumatoid arthritis? Curr Rheumatol Rep. 22, 54 (2020). doi: 10.1007/s11926-020-00934-3 (2020)

Magrey M, Charles T, Khan MA. Relationship between disease activity measures, functional status, and fibromyalgia symptom scale in ankylosing spondylitis: a cross-sectional study. J Clin Rheumatol. July 22, 2020. doi: 10.1097/RHU.0000000000001490 (2020)